Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer-Reference-Cited by-同舟云学术

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer

Published:2018-08-24 Issue:4 Volume:1 Page:e181390
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Brooks Eric D.¹,Sun Bing¹,Feng Lei²,Verma Vivek³,Zhao Lina¹,Gomez Daniel R.¹,Liao Zhongxing¹,Jeter Melenda¹,O’Reilly Michael¹,Welsh James W.¹,Nguyen Quynh-Nhu¹,Erasmus Jeremy J.⁴,Eapen George⁵,Ahrar Kamran⁶,Antonoff Mara B.⁷,Hahn Stephen M.¹,Heymach John V.⁸,Rice David C.⁷,Chang Joe Y.¹

Affiliation:

1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston

3. Department of Radiation Oncology, University of Nebraska Medical Center, Omaha

4. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston

5. Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston

6. Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston

7. Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston

8. Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/1/4/e181390/17309183/brooks_2018_oi_180090.pdf

Reference38 articles.

1. Stereotactic body radiation therapy for inoperable early stage lung cancer.;Timmerman;JAMA,2010

2. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non–small-cell lung cancer: a pooled analysis of two randomised trials.;Chang;Lancet Oncol,2015

3. 7-Year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: results of a phase 2 clinical trial.;Sun;Cancer,2017

4. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non–small-cell lung cancer: a retrospective analysis.;Senthi;Lancet Oncol,2012

5. Future of cancer incidence in the United States: burdens upon an aging, changing nation.;Smith;J Clin Oncol,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interdisciplinary Approach Toward Reirradiation of Cancer Patients;Cureus;2024-07-30

2. STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung Lesions;Diseases;2024-07-12

3. Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: Challenges and new insights;Lung Cancer;2024-07

4. Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study;BMC Cancer;2024-03-06

5. Sub-lobar resections for peripheral non-small cell lung cancer measuring ≤ 2 cm: Insights from recent clinical trials;Radiotherapy and Oncology;2024-03